"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...
DOSAGE AND ADMINISTRATION
Instill one drop in each eye once daily. If more than 1 topical ophthalmic medicinal product is being used, each one should be administered at least 5 minutes apart.
Dosage Forms And Strengths
Topical ophthalmic solution containing alcaftadine, 0.25% (2.5 mg/mL).
Storage And Handling
LASTACAFT® (alcaftadine ophthalmic solution) 0.25% is supplied in an opaque, white low-density polyethylene bottle with a white polypropylene cap.
3 mL fill in 5 mL bottle NDC 0023-4290-03
Store at 15°-25°C (59°-77°F).
Manufactured for Allergan, Inc., Irvine, CA 92612, U.S.A. by Par Sterile Products, LLC, Rochester, MI 48307. Revised: June 2014
Last reviewed on RxList: 12/22/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Lastacaft Information
Lastacaft - User Reviews
Lastacaft User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.